Compartmentalized EBNA1-GlialCAM molecular mimicry in the CSF of RR-MS patients

sponsorship: This study was funded by the Belgian Charcot Foundation (Fondation Charcot Stichting), with the support of the Fondation Jean et Marie Henkens-Lecloux. DDW holds a PhD Fellowship of the Research Foundation-Flanders (FWO-Vlaanderen;11P8K24N) JB holds a PhD Fellowship of the Research Foundation-Flanders (FWO-Vlaanderen; 11A0523N/11A0525N) MD holds a PhD Fellowship of the Research Foundation-Flanders (FWO-Vlaanderen; 11F9623N/11F9625N) ND: nothing to disclose. LY: has received funding via a KU Leuven Starting Grant, a KU Leuven C1 grant and the Belgian Charcot Foundation. BD holds a research mandate of KU Leuven (BOF-FKO, Bijzonder Onderzoeks Fonds -Fundamenteel Klinisch Onderzoeker) and has received consulting fees from Bristol Myers Squibb, Almirall, Roche, Janssen, Novartis, Sanofi, Merck, Alexion and Neuraxpharm. (Belgian Charcot Foundation (Fondation Charcot Stichting), Fondation Jean et Marie Henkens-Lecloux)

Authors

Publication Details

Journal
Lirias
Published
2025-09-01
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Compartmentalized EBNA1-GlialCAM molecular mimicry in the CSF of RR-MS patients

Dries De Wit, Lidia Yshii, Jarne Beliën, Benedicte Dubois et al.
Lirias
Glioma Diagnosis and Treatment
article

Compartmentalized EBNA1-GlialCAM molecular mimicry in the CSF of RR-MS patients

Dries De Wit, Lidia Yshii, Jarne Beliën, Benedicte Dubois, Margaux David, Nina Dedoncker
article en

Abstract

sponsorship: This study was funded by the Belgian Charcot Foundation (Fondation Charcot Stichting), with the support of the Fondation Jean et Marie Henkens-Lecloux. DDW holds a PhD Fellowship of the Research Foundation-Flanders (FWO-Vlaanderen;11P8K24N) JB holds a PhD Fellowship of the Research Foundation-Flanders (FWO-Vlaanderen; 11A0523N/11A0525N) MD holds a PhD Fellowship of the Research Foundation-Flanders (FWO-Vlaanderen; 11F9623N/11F9625N) ND: nothing to disclose. LY: has received funding via a KU Leuven Starting Grant, a KU Leuven C1 grant and the Belgian Charcot Foundation. BD holds a research mandate of KU Leuven (BOF-FKO, Bijzonder Onderzoeks Fonds -Fundamenteel Klinisch Onderzoeker) and has received consulting fees from Bristol Myers Squibb, Almirall, Roche, Janssen, Novartis, Sanofi, Merck, Alexion and Neuraxpharm. (Belgian Charcot Foundation (Fondation Charcot Stichting), Fondation Jean et Marie Henkens-Lecloux)

Lirias
Partnerships for the goals
Openalex Percentile: Top 24%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.